用于止痛的缓释氢可酮（Hysingla ER）。
Extended-release hydrocodone (Hysingla ER) for pain.
出版信息
Med Lett Drugs Ther. 2015 May 11;57(1468):71-2.
PMID:25941956
Abstract
Hysingla ER, the second single-ingredient extended-release hydrocodone product to become available in the US, is formulated for once-daily use. Zohydro ER is dosed twice daily and costs more. Both Hysingla ER and the new formulation of Zohydro ER have abuse-deterrent properties, but they will still be subject to misuse.
摘要
Hysingla ER是美国上市的第二种单成分缓释氢可酮产品，设计为每日服用一次。Zohydro ER每日服用两次，且成本更高。Hysingla ER和新配方的Zohydro ER都具有防止滥用的特性，但它们仍可能被滥用。
Zotero 插件